论文部分内容阅读
[目的]观察调中颗粒联合复方阿嗪米特治疗糖尿病胃轻瘫的临床效果。[方法]选择糖尿病胃轻瘫患者60例,随机分为治疗组30例,对照组30例;治疗组予调中颗粒联合复方阿嗪米特治疗,对照组单用复方阿嗪米特治疗,2组疗程均为4周。[结果]治疗组、对照组临床疗效总有效率分别为86.7%、60.0%,组间临床疗效比较及症状积分,差异有统计学意义(P<0.05)。[结论]调中颗粒联合复方阿嗪米特能显著缓解糖尿病胃轻瘫患者的消化道临床症状,改善胃排空。
[Objective] To observe the clinical effect of Tiaozhong granule combined with compound azinamide in treatment of diabetic gastroparesis. [Methods] Sixty patients with diabetic gastroparesis were selected and randomly divided into treatment group (n = 30) and control group (n = 30). The treatment group was treated with granule combined with compound azinamamide, while the control group with compound azinamazole alone. The two courses of treatment were 4 weeks. [Results] The total effective rates in the treatment group and the control group were 86.7% and 60.0%, respectively. The clinical efficacy and symptom scores of the two groups were statistically significant (P <0.05). [Conclusion] Tiaozhong granule combined with compound azinamide can significantly relieve the clinical symptoms of digestive tract in patients with diabetic gastroparesis and improve gastric emptying.